The Bath & Body Works, Inc. securities fraud class action lawsuit was filed on behalf of those who purchased or otherwise acquired Bath & Body Works, Inc. (“Bath & Body Works”) (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, inclusive (the “Class Period”). Captioned Muralidhar v. Bath & Body Works, Inc., et al, Case No. 2:26-cv-00039 (S.D. Ohio), the Bath & Body Works class action lawsuit alleges that Bath & Body Works and/or certain of its officers and/or directors violated federal securities laws by making false or misleading statements and/or omitted to disclose material information.
If you suffered losses as a result of your Bath & Body Works investment and want to find out more about this action and your rights, fill out the form on this page or contact attorney Jonathan Naji, Esq. of KTMC by calling (484) 270-1453 or via e-mail at info@ktmc.com.
CASE BACKGROUND:
The Class Period begins on June 4, 2024, when Bath & Body Works issued a press release touting the company’s first quarter 2024 financial results. Specifically, Bath & Body Works touted that the company's financial results were driven, in part, by a "shifted fiscal calendar" and purportedly negatively impacted merely by "weaker than expected results from certain international markets." That same day, Bath & Body Works published an investor presentation highlighting its financial results for the first quarter 2024. The investor presentation affirmed Bath & Body Works’ alleged financial results and further touted that the results were driven by, in part, “strong floorsets" and "strong execution within our fulfilment operations." The investor presentation further touted that the "year-over-year growth drivers included: Lip, Hair, Men 's and Fine Fragrance Mist,” and asserted that “Men's continued to be one of our fastest growing categories in Body Care."
On August 28, 2025, before the market opened, Bath & Body Works released its second quarter 2025 financial results. The company reported, among other things, a decline of 55.8% year-over-year in its earnings per diluted share . Bath & Body Works further reported a decline in net income of 57.9% year-over-year, and announced it was cutting its full year guidance for earnings per diluted share . On this news, Bath & Body Works’ stock price fell $2.18, or 6.9%, to close at $29.36 per share on August 28, 2025.
Then, on November 20, 2025, before the market opened, Bath & Body Works released its third quarter 2025 financial results and reported revenue declined 1% year-over-year, missing the company’s guidance of 1-3% growth for the quarter. Net income also declined, falling 26% to $77 million. Furthermore, Bath & Body Works announced it was slashing full year guidance for net sales, from a previously positive 1.5%-2.7%, to a negative “high single digits,” and cut expected earnings per diluted share from $3.28 to $3.53 to “at least $2.83.”
In an investor presentation published that same day, Bath & Body Works announced a new business strategy and admitted its strategy of “adjacencies, collaborations and promotions” had “not grown our total customer base.” The company also offered a “diagnosis” of its underperformance, including that the focus on adjacencies had “reduced focus on investing in our core categories;” that collaborations “have been used to carry quarters;” and that Bath & Body Works had become “overly reliant on deeper and more frequent promotions to drive growth.” Finally, Bath & Body Works announced it would exit certain adjacencies and instead focus on core categories. On this news, Bath & Body Works’ stock price fell $5.22, or 24.8%, to close at $15.82 per share on November 20, 2025.
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Bath & Body Works’ strategy of pursuing “adjacencies, collaborations and promotions” was not growing the customer base and/or delivering the level of growth in net sales as touted; (2) as Bath & Body Works’ strategy of “adjacencies, collaborations and promotions” faltered, Bath & Body Works relied on brand collaborations “to carry quarters” and obfuscate otherwise weak underlying financial results; (3) as a result, Bath & Body Works was unlikely to meet its own previously issued financial guidance; (4) as a result of the foregoing, Defendants’ positive statements about the company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
THE LEAD PLAINTIFF PROCESS:
The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Bath & Body Works securities during the Class Period to seek appointment as lead plaintiff in the Bath & Body Works class action lawsuit. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Filling out the online form above or communicating with any counsel is not necessary to participate or share in any recovery achieved in this case. Any member of the purported class may move the court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California.